Asset 18.png
Charlie Vaske, PhD.png

Charlie Vaske

NantOmics
Culver City, California

CBTN Data

966

CBTN Participants

About this

Project

Treating pediatric cancers requires a robust understanding of the mechanisms of tumor growth and progression, as well as an understanding of the differences between tumor types. This project seeks to generate mutational, transcriptional, and integrative profiles of individual tumors. Researchers will compare samples to each other to find sub-groupings of samples, and determine which features define those groupings. Understanding these groupings could lead to the identification of targets for therapeutics. The purpose of these comparisons will be to further refine the set of potential gene and pathway targets for the treatment of pediatric brain cancers. Researchers will apply integrative analysis of data types to find potential novel drug targets and matching of therapeutics. The Children's Brain Tumor Network contributed to this project by providing access to the Pediatric Brain Tumor Atlas.

Ask The

Scientists

Ask the scientists

What are the goals of this project?

Researchers will analyze pediatric cancer data to characterize key elements of the tumors.

What is the impact of this project?

Understanding the key characteristics for tumor types will provide improvement to identify potential new diagnostic indicators and therapeutic targets.

Why is the CBTN request important to this project?

Work like this project requires comprehensive, high quality data across cancer types, making access to the Pediatric Brain Tumor Atlas integral.

Specimen Data

The Children's Brain Tumor Network contributed to this project by providing access to the Pediatric Brain Tumor Atlas.

Explore the data in these informatics portals

Cavativa-Logo.png

Meet The

Team

Collaborators:

  • Zack Sanborn at NantOmics
  • Yulia Newton at NantOmics
  • AJ Sedgewick at NantOmics
  • Bobby Reddy at NantHealth
  • Kayvan Niazi at NantBio
  • Lennie Sender at NantKwest

Charlie Vaske, PhD.png

Charlie Vaske, PhD

Nantomics-logo.jpg

NantOmics

Culver City, California
Default person avatar

Shahrooz Rabizadeh, PhD

Nantomics-logo.jpg

NantOmics

Culver City, California
Olena-Morozova-e1499896145315.jpg

Scientific Committee

Principal Investigator

Olena Morozova Vaske, PhD

Dr. Vaske is the Co-Founder of the Treehouse Childhood Cancer Initiative at the University of California Santa Cruz Genomics Institute where she is an Assistant Professor of Molecular, Cell and Developmental Biology. She is a Fellow of the Canadian College of Medical Geneticists and holds the Univer

UCSC TreeHouse Childhood Cancer Initiative.jpg

UC Santa Cruz Treehouse Childhood Cancer Initiative

Santa Cruz, CA, USA
Default person avatar

Steve Benz, PhD

Nantomics-logo.jpg

NantOmics

Culver City, California
Mueller_Sabine_2019-740x864.jpg

Scientific Committee

Executive Board

Sabine Mueller, MD, PhD

Dr. Sabine Mueller is a pediatric neuro-oncologist who specializes in caring for children with brain tumors and related genetic syndromes. Before completing medical school, she worked as a scientist, director of genomics and project leader for a brain tumor program at AGY Therapeutics, a biotechnolo

UCSF Benioff Children's Hospital.jpg

UCSF Benioff Children's Hospital

San Francisco and Oakland, CA, USA
ewc_CHOPFoundation(1)01201604184.jpg

Scientific Committee

Executive Board

Scientific co-Chair

Principal Investigator

Adam Resnick, PhD

Adam Resnick is the Director of Data Driven Discovery in Biomedicine (D3b) at Children’s Hospital of Philadelphia (CHOP) responsible for leading a multidisciplinary team to build and support a scalable, patient-focused healthcare and educational discovery ecosystem on behalf of all children. He is a

CHOP.jpg

Children’s Hospital of Philadelphia

Philadelphia, PA, USA
Javad Nazarian PhD.jpg

Scientific Committee

Executive Board

Principal Investigator

Javad Nazarian, PhD, MSc

I am an investigator at the Center for Genetic Medicine in Children’s National Hospital in Washington, D.C., and an assistant professor in Integrative Systems Biology at the George Washington University. I received my PhD from the George Washington University in Genetics in 2005. My dissertation res

CNHS.jpg

Children’s National Hospital

Washington, DC, USA

Institutions

Nantomics-logo.jpg

NantOmics

Our mission is to provide comprehensive personalized molecular solutions to inform cancer care.NantOmics, a member of the NantWorks ecosystem of companies, is a leader in molecular diagnostic testing and the first company to employ an integrated panomic approach to inform personalized treatment opti

UCSC TreeHouse Childhood Cancer Initiative.jpg

Satellite

UC Santa Cruz Treehouse Childhood Cancer Initiative

Joined on

The Treehouse Childhood Cancer Initiative was established to analyze genomic data of children with cancer in the context of large data sets of both pediatric and adult cancers. This allows researchers to identify situations where an available drug is predicted to work for a given patient’s tumor. Tr

UCSF Benioff Children's Hospital.jpg

Primary

ucsfbenioffchildrens_logo.png

UCSF Benioff Children's Hospital

Joined on

The Pediatric Brain Tumor Center at UCSF Benioff Children’s Hospital, with campuses in San Francisco and Oakland, harnesses the power of world-class experts from all disciplines related to child brain health, including neurology, neurosurgery, neurocritical care, neurogenetics, neuro-oncology, rehab

CHOP.jpg

Primary

Operations Center

chop-logo-bl.png

Children’s Hospital of Philadelphia

Joined on

Operations Center for the Children’s Brain Tumor Tissue Consortium, the Children’s Hospital of Philadelphia (CHOP) is currently ranked 1st nationally for their Pediatric Cancer Program by U.S. News & World Report. CHOP’s Biobank is home to the CBTTC’s pediatric brain and CNS tumor biorepository; the

CNHS.jpg

Primary

Children’s National Hospital

Joined on

Each year, the Brain Tumor Institute at Children’s National evaluates more than 100 new patients with brain tumors, and is recognized as a world leader in childhood brain tumor care and research. Children’s National has pioneered novel pediatric brain tumor therapies, including new molecularly-targe

related

Histologies